By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Addex Therapeutics 

12, Chemin Des Aulx
1228 Plan-les-Ouates
Geneva      Switzerland
Phone: 41-22-884-1555 Fax: 41-22-884-1556




Company News
Addex Therapeutics (ADXN.SW) Reports First Half 2015 Financial Results 9/30/2015 8:58:01 AM
Addex Therapeutics (ADXN.SW) ADX71149 Demonstrates Synergistic Efficacy With Levetiracetam In Preclinical Models Of Epilepsy 9/23/2015 9:11:26 AM
Pierre Fabre And Addex Therapeutics (ADXN.SW) Sign Early-Stage Agreement In The Central Nervous System (CNS) Field 9/8/2015 10:33:04 AM
Alpha Deal Group Initiates Independent Research Coverage On Addex Therapeutics (ADXN.SW) 8/17/2015 9:48:19 AM
Addex Therapeutics (ADXN.SW) Dipraglurant Demonstrates Anxiolytic- And Antidepressant-Like Activity In Multiple Preclinical Models Relevant For Non-Motor Symptoms In Parkinson's Disease 8/14/2015 9:14:32 AM
valuationLAB Issues Research Report On Addex Therapeutics (ADXN.SW) 8/5/2015 9:35:12 AM
Addex Therapeutics (ADXN.SW) Dipraglurant Dosed In First Subject In Receptor Occupancy Study In Collaboration With Johns Hopkins University And With Funding From The Michael J. Fox Foundation 7/22/2015 10:50:44 AM
Addex Therapeutics (ADXN.SW) Shareholders Appoint Raymond Hill And Tim Dyer To The Board Of Directors And Approve All Board Proposals At Annual General Meeting 6/12/2015 8:54:16 AM
Addex Therapeutics (ADXN.SW) Identifies New Potential Use Of mGlu7 Receptor NAMs To Treat Stress-Induced Visceral Pain 6/3/2015 7:45:21 AM
Addex Therapeutics (ADXN.SW) And Prof. Pisani Present Dipraglurant Data In Rare Inherited Forms Of Dystonia 5/29/2015 8:58:53 AM